Max Chat
Astellas Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
174.58 | 112.41 | 55.3% | 55.79 | +212.94% |
| P/S |
|
1.86 | 75.54 | -97.54% |
|
|
| P/BV |
|
1.86 | 70.29 | -97.35% |
|
|
| P/FCF |
|
44.57 | 28.67 | 55.46% |
|
|
| Ev/Ebitda |
|
18.66 | 29.32 | -36.34% |
|
|
| Ev/S |
|
2.27 | 73.15 | -96.89% |
|
|
| Ev/FCF |
|
40.52 | 27.26 | 48.66% |
|
|
| E/P |
|
0.0043 | 0.4676 | -99.08% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
12.18 | -49.16 | -124.78% | 15.28 | -20.3% |
| ROE |
|
1.1 | 1.13 | -3.04% |
|
|
| ROA |
|
0.5657 | 0.6587 | -14.12% |
|
|
| ROIC |
|
12.61 | 9.07 | 38.96% |
|
|
| ROS |
|
1.06 | -83.08 | -101.28% |
|
|
| ROCE |
|
2.35 | -1.97 | -219.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.15 | 4.43 | 16.24% | 2.65 | +93.93% |
| Nеt Debt/Ebitda |
|
3.43 | 15.16 | -77.37% |
|
|
| Debt/Ratio |
|
0.2817 | 0.1487 | 89.44% |
|
|
| Debt/Equity |
|
1.24 | 1.11 | 11.79% |
|
|
| Debt/Net Income |
|
59 | -2.47 | -2490.8% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.92 | 2.86 | 141.65% | 4.8 | +44.17% |
| Number of years of dividend growth |
|
3 | 1.43 | 109.43% | ||
| DSI |
|
0.9286 | 0.7453 | 24.59% |
|
|
| Average dividend growth |
|
10.51 | -140.78 | -107.46% |
|
|
| Average percentage for 5 years |
|
4.8 | 38.17 | -87.42% |
|
|
| Average percentage for payments |
|
164.66 | 34.62 | 375.59% |
|
|
| Difference from average difference in sector |
|
4.06 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
23.28 | 1533.14 | -98.48% | ||
| Growth impulse Ebitda in 5 years |
|
-37.94 | 3726.29 | -101.02% | ||
| Growth impulse Net Income in 5 years |
|
-91.28 | 2596.48 | -103.52% | ||
| Growth impulse FCF in 5 years |
|
-37.56 | 2353.76 | -101.6% | ||
| Growth impulse EPS in 5 years |
|
-90.9 | 3216.29 | -102.83% |
IP Score
4.37/10
